Hepatitis C: Enhancing treatment for hepatitis C among drug users.
Jason
J
Grebely
Gregory J
GJ
Dore
D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D055030:Drug Users; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D010349:Patient Compliance; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b